Mankind Pharma Shares Surge 8% After Q2 Earnings Beat
Mankind Pharma shares rose more than 8% intraday on Tuesday, October 27, their biggest single-day gain in nearly two weeks. JPMorgan maintained its neutral rating and Rs 2,700 target.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Mankind Pharma shares rose more than 8% intraday on Tuesday, October 27, their biggest single-day gain in nearly two weeks. JPMorgan maintained its neutral rating and Rs 2,700 target.